Health services

The pharmaceutical company is aiming to uphold patient access to licensed treatment options for wet AMD

Bayer and Novartis have been unsuccessful in their case against a policy adopted by CCGs in the North of England

While emphasising that a departure from the EU without agreement is ‘unlikely,’ the Government has released guidance on potential healthcare implications

A new report has found that the AMD market across the US, France, Germany, Italy, Spain, Japan and the UK is expected to grow at a rate of 8.9%

Ophthalmology sales in 2017 were led by AMD treatments, new analysis has revealed

The General Medical Council has responded to new NICE guidelines for treating AMD

A cancer drug is being offered as a treatment option for wet AMD, but 12 CCGs face legal action

Limerick-based ophthalmic surgeon and retinal specialist, David Kent, tells OT  about becoming the first clinician in Ireland to administer a new treatment for chronic diabetic macular oedema

Spark Therapeutics put in application as it published positive phase 3 clinical trial results

NICE guidance recommends the use of Humira for the treatment of eye condition